| Literature DB >> 36072647 |
Pravat K Mandal1,2, Anshika Goel1, Ashley I Bush2,3,4, Khushboo Punjabi1, Shallu Joon1, Ritwick Mishra1, Manjari Tripathi5, Arun Garg6, Natasha K Kumar6, Pooja Sharma7, Deepika Shukla1, Scott Jonathan Ayton2,3,4, Amir Fazlollahi8, Joseph C Maroon9, Divya Dwivedi1, Avantika Samkaria1, Kanika Sandal1, Kanu Megha1, Sandhya Shandilya1.
Abstract
Oxidative stress has been implicated in Alzheimer's disease, and it is potentially driven by the depletion of primary antioxidant, glutathione, as well as elevation of the pro-oxidant, iron. Present study evaluates glutathione level by magnetic resonance spectroscopy, iron deposition by quantitative susceptibility mapping in left hippocampus, as well as the neuropsychological scores of healthy old participants (N = 25), mild cognitive impairment (N = 16) and Alzheimer's disease patients (N = 31). Glutathione was found to be significantly depleted in mild cognitive impaired (P < 0.05) and Alzheimer's disease patients (P < 0.001) as compared with healthy old participants. A significant higher level of iron was observed in left hippocampus region for Alzheimer's disease patients as compared with healthy old (P < 0.05) and mild cognitive impairment (P < 0.05). Multivariate receiver-operating curve analysis for combined glutathione and iron in left hippocampus region provided diagnostic accuracy of 82.1%, with 81.8% sensitivity and 82.4% specificity for diagnosing Alzheimer's disease patients from healthy old participants. We conclude that tandem glutathione and iron provides novel avenue to investigate further research in Alzheimer's disease.Entities:
Keywords: Alzheimer’s disease brain; glutathione; hippocampus; quantitative susceptibility mapping
Year: 2022 PMID: 36072647 PMCID: PMC9445173 DOI: 10.1093/braincomms/fcac215
Source DB: PubMed Journal: Brain Commun ISSN: 2632-1297